scholarly journals Reply to: “Characterization of acute acro-ischemic lesions in non-hospitalized patients: A case series of 132 patients during the COVID-19 outbreak”

2020 ◽  
Vol 83 (3) ◽  
pp. e237-e239
Author(s):  
Giuseppe Ruggiero ◽  
Fabio Arcangeli ◽  
Torello Lotti ◽  
Orsola Ametrano ◽  
Cosimo Ruggiero ◽  
...  
2020 ◽  
Vol 83 (3) ◽  
pp. e241 ◽  
Author(s):  
Diego Fernandez-Nieto ◽  
Juan Jimenez-Cauhe ◽  
Ana Suarez-Valle ◽  
Oscar M. Moreno-Arrones ◽  
David Saceda-Corralo ◽  
...  

Pathogens ◽  
2021 ◽  
Vol 10 (3) ◽  
pp. 328
Author(s):  
Daniel Hubert ◽  
Roger Dumke ◽  
Stefan Weichert ◽  
Sybille Welker ◽  
Tobias Tenenbaum ◽  
...  

Mycoplasma pneumoniae (M. pneumoniae) is a common causative pathogen of community-acquired pneumonia. Here, we report the development of macrolide resistance during a school outbreak of severe M. pneumoniae infections in southwest Germany. We conducted a case series to assess the clinical and laboratory characteristics of hospitalized children with M. pneumonia infection and the prevalence of macrolide-resistant M. pneumoniae (MRMP) in this patient group. We retrospectively analyzed 23 children with serologically (19 patients) and/or PCR (eight patients) confirmed M. pneumoniae infection between October 2019 and December 2019. Most of the 15 hospitalized patients had lower respiratory tract infection (n = 10) and required oxygen therapy (83%). The median length of hospitalization was 7 days (range 3–10 days). In 8/15 patients (53.3%) azithromycin and in 4/15 (26.6%) clarithromycin treatment was applied. However, among the five patients for which extended molecular characterization was performed, sequencing of 23S rRNA revealed no mutation only in the first case, but development of macrolide resistance A2058G in four subsequent cases. Hence, we identified a cluster of hospitalized patients with emerging MRMP. Further studies are warranted to confirm a potential link between macrolide resistance and disease severity.


2021 ◽  
Vol 77 (18) ◽  
pp. 3087
Author(s):  
Naveena Yanamala ◽  
Nanda H. Krishna ◽  
Quincy Hathaway ◽  
Aditya Radhakrishnan ◽  
Srinidhi Sunkara ◽  
...  

Author(s):  
Jose‐Manuel Ramos‐Rincon ◽  
Oscar Moreno‐Perez ◽  
Hector Pinargote‐Celorio ◽  
Jose‐Manuel Leon‐Ramirez ◽  
Mariano Andres ◽  
...  

2015 ◽  
Vol 123 (4) ◽  
pp. 1036-1041 ◽  
Author(s):  
Hiroki Kanamori ◽  
Yohei Kitamura ◽  
Tokuhiro Kimura ◽  
Kazunari Yoshida ◽  
Hikaru Sasaki

OBJECT Although chondrosarcomas rarely arise in the skull base, chondrosarcomas and chordomas are the 2 major malignant bone neoplasms occurring at this location. The distinction of these 2 tumors is important, but this distinction is occasionally problematic because of radiological and histological overlap. Unlike chordoma and extracranial chondrosarcoma, no case series presenting a whole-genome analysis of skull base chondrosarcomas (SBCSs) has been reported. The goal of this study is to clarify the genetic characteristics of SBCSs and contrast them with those of chordomas. METHODS The authors analyzed 7 SBCS specimens for chromosomal copy number alterations (CNAs) using comparative genomic hybridization (CGH). They also examined IDH1 and IDH2 mutations and brachyury expression. RESULTS In CGH analyses, the authors detected CNAs in 6 of the 7 cases, including chromosomal gains of 8q21.1, 19, 2q22-q32, 5qcen-q14, 8q21-q22, and 15qcen-q14. Mutation of IDH1 was found with a high frequency (5 of 7 cases, 71.4%), of which R132S was most frequently mutated. No IDH2 mutations were found, and immunohistochemical staining for brachyury was negative in all cases. CONCLUSIONS To the best of the authors' knowledge, this is the first whole-genome study of an SBSC case series. Their findings suggest that these tumors are molecularly consistent with a subset of conventional central chondrosarcomas and different from skull base chordomas.


2003 ◽  
Vol 41 (6) ◽  
pp. 2330-2336 ◽  
Author(s):  
R. Jureen ◽  
J. Top ◽  
S. C. Mohn ◽  
S. Harthug ◽  
N. Langeland ◽  
...  

2011 ◽  
Vol 2011 ◽  
pp. 1-7
Author(s):  
Kourosh Parsapour ◽  
Alexander A. Kon ◽  
Madan Dharmar ◽  
Amy K. McCarthy ◽  
Hsuan-Hui Yang ◽  
...  

The overall aim of this project was to ascertain the utilization of a custom-designed telemedicine service for patients to maintain close contact (via videoconference) with family and friends during hospitalization. We conducted a retrospective chart review of hospitalized patients (primarily children) with extended hospital length of stays. Telecommunication equipment was used to provide videoconference links from the patient's bedside to friends and family in the community. Thirty-six cases were managed during a five-year period (2006 to 2010). The most common reasons for using Family-Link were related to the logistical challenges of traveling to and from the hospital—principally due to distance, time, family commitments, and/or personal cost. We conclude that videoconferencing provides a solution to some barriers that may limit family presence and participation in care for hospitalized patients, and as a patient-centered innovation is likely to enhance patient and family satisfaction.


Sign in / Sign up

Export Citation Format

Share Document